Sang-Yoon Lee

Sang-Yoon Lee is an experienced medical professional currently serving as the Director of Clinical Science at Chong Kun Dang Pharm. since January 2025. Prior to this role, Sang-Yoon Lee was the Chief Medical Officer and Head of Oncology at Bridge Biotherapeutics, Inc. from April 2021 to May 2025, focusing on clinical trial management and collaboration for innovative drug development. Additionally, experience includes leading research and development at Interpark Bio Convergence Center, overseeing clinical research at HANDOK, and serving in various roles at Pfizer, where achievements involved successful drug launches and clinical trial oversight. Sang-Yoon Lee's foundational education includes a medical degree from Seoul National University and extensive training in hematology, medical oncology, and internal medicine at prestigious institutions.